These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16681980)

  • 1. [Side effects of adjuvant chemotherapy and radiotherapy concurrently after conservative surgery for breast cancer].
    Liu P; Yang DQ; Qiao XM; Cao YM; Liu HJ; Wang S; Cheng L
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):854-6. PubMed ID: 16681980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy of women with breast cancer - information, support and side-effects.
    Sjövall K; Strömbeck G; Löfgren A; Bendahl PO; Gunnars B
    Eur J Oncol Nurs; 2010 Apr; 14(2):147-53. PubMed ID: 19896896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
    Han S; Kim J; Sohn S; Kwak GH; Kim JY; Park K
    J Surg Oncol; 2007 Jan; 95(1):45-50. PubMed ID: 17192866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients.
    Rutqvist LE; Johansson H
    Acta Oncol; 2006; 45(5):517-27. PubMed ID: 16864164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of delaying adjuvant radiation treatment after conservative surgery for early breast cancer.
    Cèfaro GA; Genovesi D; Marchese R; Di Tommaso M; Di Febo F; Ballone E; Di Nicola M
    Breast J; 2007; 13(6):575-80. PubMed ID: 17983399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
    Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
    Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant negative impact of adjuvant chemotherapy on health-related quality of life (HR-QoL) in women with breast cancer treated by conserving surgery and postoperative 3-D radiotherapy. A prospective measurement.
    Galalae RM; Michel J; Siebmann JU; Küchler T; Eilf K; Kimmig B
    Strahlenther Onkol; 2005 Oct; 181(10):645-51. PubMed ID: 16220403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
    Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
    Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
    J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast-conserving therapy for centrally located primary breast cancer].
    Li JF; Ouyang T; Wang TF; Xie YT; Fan ZQ; Lin BY
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):478-80. PubMed ID: 17152501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
    Liu CP; Shi L; Li Z
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative radiotherapy in the conservative treatment for breast cancer.
    Nardone L; Ausili-Cèfaro G; Palazzoni G; Gentile PC; Salvi G; Marmiroli L
    Rays; 1997; 22(3):417-24. PubMed ID: 9446946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives.
    Tsoutsou PG; Koukourakis MI; Azria D; Belkacémi Y
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):102-16. PubMed ID: 18922700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
    Massidda B; Atzori F; Scanu A; Contu A; Farris A; Catino AM; Palmeri S; Minerba L; Ionta MT
    Oncology; 2007; 72(1-2):17-26. PubMed ID: 17998786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in young women: case report and a review.
    Batori M; Ruggieri M; Chatelou E; Straniero A; Mariotta G; Palombi L; Casella G; Basile M; Casella MC
    Eur Rev Med Pharmacol Sci; 2006; 10(2):51-2. PubMed ID: 16705948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
    Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.